Valbiotis Is A French Biotechnology Company Founded In 2014 And Based In La Rochellefrancethe Company Specializes In Preventive Healthcaredeveloping Scientifically Validated Dietary Supplements And Nutritional Solutions Aimed At Combating Metabolic And Cardiovascular Diseasesvalbiotis Has Been Publicly Traded On Euronext Growth Paris Since Its Ipo In June 2017 The Company Employs A Multi Target Strategyutilizing Marine And Terrestrial Plant Based Resources To Create Products That Address Risk Factors For Chronic Diseasesincluding Type 2 Diabetesobesityand Cardiovascular Issuesvalbiotis Also Focuses On Medical Nutrition Solutions With Clinically Proven Effects And Sells Its Products Directly To Consumers Through An E Commerce Platformthe Company Collaborates With Academic Partners For Clinical Trials And Has Received Recognition As Aninnovative Companyfrom Bpifrancevalbiotis Aims To Expand Its Product Pipeline And Commercial Reach As Part Of Its Strategic Goals For 2030
No conferences found for this company.
| Company Name | Valbiotis Sas |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
